Biofrontera (BFRI)

• Market cap: $7.54M
• 1 day: 1.80%
• 5 days: 8.32%
• 1 month: -15.84%
• 3 months: -22.73%
• 6 months: 13.18%
• Year to date: -22.02%
• 1 year: -50.29%
• 5 years: -99.04%
• 10 years: -99.04%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Employees: 93

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

56% more funds holding

Funds holding: 9 [Q3] → 14 (+5) [Q4]

38% more capital invested

Capital invested by funds: $1.43M [Q3] → $1.97M (+$546K) [Q4]

3.98% more ownership

Funds ownership: 19.36% [Q3] → 23.35% (+3.98%) [Q4]